|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.57 AUD | -2.80% |
|
+1.32% | -8.94% |
| Mar. 14 | Clinuvel Pharmaceuticals Launches Share Buyback Program | MT |
| Mar. 14 | Morgans Financial Upgrades Clinuvel Pharmaceuticals to Add From Hold; Price Target is AU$16 | MT |
Clinuvel Pharmaceuticals Limited (ASX:CUV) announces a share repurchase program. Under the program, the company will repurchase up to 1,500,000 shares, representing 2.99% of its share capital. The program will expire on March 27, 2025.
As of March 14, 2024, the company had 50,127,270 shares in issue.
| 1st Jan change | Capi. | |
|---|---|---|
| -8.94% | 476M | |
| -4.66% | 86.13B | |
| +1.32% | 39.82B | |
| -19.27% | 30.42B | |
| +57.86% | 25.23B | |
| -17.69% | 11.6B | |
| -43.00% | 11.51B | |
| -9.14% | 11.95B | |
| +5.24% | 8.71B | |
| -8.42% | 8.12B |
CLINUVEL PHARMACEUTICALS LIMITED 
